SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression.
Nature Communications
Hou, Guojun G; Harley, Isaac T W ITW; Lu, Xiaoming X; Zhou, Tian T; Xu, Ning N; Yao, Chao C; Qin, Yuting Y; Ouyang, Ye Y; Ma, Jianyang J; Zhu, Xinyi X; Yu, Xiang X; Xu, Hong H; Dai, Dai D; Ding, Huihua H; Yin, Zhihua Z; Ye, Zhizhong Z; Deng, Jun J; Zhou, Mi M; Tang, Yuanjia Y; Namjou, Bahram B; Guo, Ya Y; Weirauch, Matthew T MT; Kottyan, Leah C LC; Harley, John B JB; Shen, Nan N
Dynein and dynactin leverage their bivalent character to form a high-affinity interaction.
Plos One
Siglin, Amanda E AE; Sun, Shangjin S; Moore, Jeffrey K JK; Tan, Sarah S; Poenie, Martin M; Lear, James D JD; Polenova, Tatyana T; Cooper, John A JA; Williams, John C JC